Patent · US Active

Application of mRNA for use as a therapeutic against tumour diseases

US9655955B2 · kind B2 · utility

34Cited by

44References

20Claims

0Family size

Assignee

CureVac AG · DE

Inventors

Ingmar Hoerr · Tübingen, DE
Florian Von Der Mülbe · Stuttgart, DE
Steve Pascolo · Tübingen, DE

Key dates

Filing date	Dec 10, 2015
Grant date	May 23, 2017
Priority date	—
Expiry date	Dec 10, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/70
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a pharmaceutical composition comprising at least one mRNA comprising at least one coding region for at least one antigen from a tumor, in combination with an aqueous solvent and preferably a cytokine, e.g. GM-CSF, and a process for the preparation of the pharmaceutical composition. The pharmaceutical composition according to the invention is used in particular for therapy and/or prophylaxis against cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.